Handumon, Esterlita .
HRN: 06-48-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2022
CEFUROXIME 1.5GM (VIAL)
06/03/2022
06/04/2022
IVT
1.5
Q8
S/P LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes